Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

BBIO Q1 2018 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena

BBIOBridgeBio Pharma, Inc.

$14B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$42M

Net Income

-$34M

EPS (Diluted)

$-0.37

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$33M

Stock-Based Comp.

$751,000

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$86M

Cash & Equivalents

-$92M

← FY 2018 All Quarters Q2 2018 →